SPBC887.13c Antibody

What is SPBC887.13c and what cellular functions does it participate in?

SPBC887.13c is a mitochondrial protein in Schizosaccharomyces pombe (fission yeast) that functions as a putative 3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41), also known as beta-ketoacyl-ACP synthase or mtKAS. This enzyme plays a crucial role in the biosynthesis of lipoic acid and longer-chain fatty acids, which are essential for optimal mitochondrial function. The protein belongs to the beta-ketoacyl-ACP synthases family and is localized to the mitochondrion. Research suggests that SPBC887.13c contributes to mitochondrial fatty acid synthesis, which is distinct from cytosolic fatty acid synthesis and is critical for cellular respiratory functions.

What are the recommended applications for SPBC887.13c antibody in research?

SPBC887.13c antibody can be utilized in multiple experimental applications focusing on mitochondrial function and fatty acid synthesis pathways. While the search results don't explicitly list all applications, based on standard antibody utilization patterns for mitochondrial proteins and the characteristics of similar antibodies, researchers can consider employing this antibody for:

• Western blotting to detect and quantify SPBC887.13c protein expression

• Immunofluorescence microscopy to visualize mitochondrial localization patterns

• Immunoprecipitation to isolate protein complexes associated with fatty acid synthesis

• Flow cytometry to analyze mitochondrial protein expression in individual cells

• Immunohistochemistry to examine tissue distribution in model organisms

The specific application should be validated experimentally as different antibody preparations may perform differently across methodologies.

What sample preparation techniques are recommended for optimal SPBC887.13c antibody performance?

For optimal results when working with the SPBC887.13c antibody, consider the following sample preparation recommendations:

For mitochondrial proteins like SPBC887.13c, careful isolation of the mitochondrial fraction is often crucial. Begin with gentle cell lysis methods to preserve mitochondrial integrity, followed by differential centrifugation to isolate the mitochondrial fraction. For S. pombe specifically, standard protocols involve spheroplasting followed by membrane preparation as outlined in similar research methodologies . When preparing samples for Western blotting, mitochondrial membrane proteins may require specialized lysis buffers containing appropriate detergents (such as CHAPS or digitonin) to maintain protein structure while ensuring solubilization. For immunofluorescence applications, methanol fixation protocols have been successfully employed for similar mitochondrial protein detection in fission yeast .

For protease protection assays that can help confirm the mitochondrial localization and topology of SPBC887.13c, consider adapting protocols similar to those described for other mitochondrial proteins, which typically involve treating isolated mitochondria with proteinase K under various conditions to determine protein orientation .

How can researchers distinguish between SPBC887.13c and other beta-ketoacyl-ACP synthases when using antibodies?

Distinguishing SPBC887.13c from other related beta-ketoacyl-ACP synthases requires careful experimental design and appropriate controls. First, researchers should evaluate antibody specificity using knockout validation approaches. A recommended methodology involves comparing antibody reactivity in wild-type S. pombe versus strains with SPBC887.13c deletion or controlled expression (such as through nmt81-promoter systems similar to those used for other essential S. pombe genes) .

For more comprehensive validation, researchers might consider:

• Competitive binding assays using recombinant SPBC887.13c protein

• Cross-reactivity testing against related ACP synthases expressed in the same system

• Immunoprecipitation followed by mass spectrometry to confirm target specificity

• Western blot analysis comparing pattern recognition across mutant strains

What are the optimal experimental conditions for detecting SPBC887.13c in its native mitochondrial environment?

Detecting SPBC887.13c in its native mitochondrial environment requires consideration of several experimental parameters:

For immunofluorescence microscopy, co-staining with established mitochondrial markers is essential to confirm localization. Consider using fixation methods that preserve mitochondrial morphology, such as 4% paraformaldehyde followed by permeabilization with 0.1% Triton X-100. Methanol fixation protocols have been effectively used for immunofluorescence labeling of mitochondrial proteins in S. pombe . For optimal results, compare multiple fixation protocols to determine which best preserves epitope accessibility while maintaining mitochondrial structure.

For biochemical analyses, subcellular fractionation followed by Western blotting provides reliable detection. The antibody should be used at empirically determined concentrations, typically starting with a 1:1000 dilution in blocking buffer containing 5% BSA or non-fat dry milk in TBST, then optimized based on signal-to-noise ratio. When analyzing SPBC887.13c in its native environment, consider gentle solubilization methods that preserve protein-protein interactions, such as digitonin-based buffers (0.5-2%) that have been successful for other mitochondrial membrane proteins.

What are the recommended controls for validating SPBC887.13c antibody specificity in experimental systems?

Rigorous validation of SPBC887.13c antibody specificity requires multiple complementary approaches:

• Genetic controls: Compare antibody reactivity between wild-type cells and those with modulated SPBC887.13c expression (knockdown, knockout, or overexpression systems where feasible). For essential genes like SPBC887.13c may be, conditional expression systems (such as the nmt81-promoter system used in S. pombe) can provide a suitable alternative to complete knockouts.

• Peptide competition assays: Pre-incubation of the antibody with excess purified target antigen or immunizing peptide should abolish specific signal in Western blot, immunofluorescence, or other detection methods.

• Recombinant protein standards: Include purified recombinant SPBC887.13c as a positive control for size verification and signal specificity.

• Cross-reactivity assessment: Test the antibody against related beta-ketoacyl-ACP synthases to ensure it specifically recognizes SPBC887.13c.

• Mass spectrometry validation: Following immunoprecipitation with the SPBC887.13c antibody, mass spectrometry analysis can confirm identity of the pulled-down protein.

Documentation of these validation steps is essential for publication and ensuring reproducibility of research findings involving SPBC887.13c.

How can researchers overcome common technical challenges when using SPBC887.13c antibody in co-immunoprecipitation experiments?

Co-immunoprecipitation (Co-IP) experiments with mitochondrial proteins like SPBC887.13c present several technical challenges:

• Membrane protein solubilization: SPBC887.13c is a mitochondrial protein, potentially making complete solubilization difficult. To overcome this, use a range of detergents (CHAPS, digitonin, or DDM) at different concentrations (0.5-2%) to identify optimal solubilization conditions that preserve protein-protein interactions. Test each condition by Western blot before proceeding to full Co-IP experiments.

• Maintaining physiological interactions: Cross-linking approaches prior to lysis (using formaldehyde at 0.1-1% or specialized crosslinkers) may help preserve transient interactions. Consider adapting protocols from studies of other mitochondrial membrane proteins.

• Reducing background: Include stringent washing steps with buffers containing low concentrations of detergent (0.1% Triton X-100 or NP-40) while balancing the need to maintain specific interactions. Pre-clearing lysates with Protein A/G beads before adding the antibody can significantly reduce non-specific binding.

• Antibody orientation: Consider using antibody-coupling kits to covalently attach the SPBC887.13c antibody to beads, preventing antibody heavy and light chains from obscuring detection of interacting proteins of similar molecular weights.

• Confirming specificity: Always include appropriate negative controls, such as immunoprecipitation with non-specific IgG or lysates from cells with reduced SPBC887.13c expression.

What strategies can address inconsistent SPBC887.13c antibody performance across different experimental batches?

Inconsistent antibody performance across batches is a common challenge in research. To address this with SPBC887.13c antibody:

• Standardized storage and handling: Store antibody aliquots at -20°C or -80°C to minimize freeze-thaw cycles. The SPBC887.13c antibody is supplied in a buffer containing 50% glycerol, 0.01M PBS pH 7.4, and 0.03% Proclin 300 as a preservative, which helps maintain stability.

• Lot testing and validation: When receiving a new lot, perform side-by-side comparison with previous lots using consistent positive control samples. Document lot-specific optimal dilutions and conditions.

• Internal controls: Include consistent positive control samples in each experiment to normalize for batch-to-batch variation. For Western blots, consider including recombinant SPBC887.13c protein as a standard.

• Detailed protocol documentation: Maintain detailed records of experimental conditions, including buffer compositions, incubation times/temperatures, and detection methods. This allows systematic troubleshooting when performance varies.

• Epitope accessibility checks: If inconsistency persists, investigate whether sample preparation methods might be affecting epitope accessibility. Different fixation methods or antigen retrieval approaches may need to be tested.

• Consider recombinant antibodies: For critical experiments, recombinant antibody formats often provide superior batch-to-batch consistency, similar to how recombinant antibodies against other proteins (like Cytokeratin 13 ) have demonstrated unrivaled batch-to-batch consistency.

How can researchers optimize SPBC887.13c antibody detection sensitivity for low-abundance expression scenarios?

Detecting low-abundance mitochondrial proteins like SPBC887.13c may require enhanced sensitivity approaches:

• Signal amplification systems: Consider using tyramide signal amplification (TSA) or polymer-based detection systems that can increase sensitivity by 10-100 fold for immunohistochemistry or immunofluorescence applications.

• Sample enrichment: For biochemical analyses, enrich for mitochondrial fractions through subcellular fractionation techniques, effectively concentrating the target protein before antibody application.

• Enhanced chemiluminescence: For Western blotting, use high-sensitivity ECL substrates specifically designed for detecting low-abundance proteins. Extended exposure times with high-sensitivity cameras can further improve detection.

• Sample loading optimization: Increase total protein loading while ensuring compatible running conditions. For mitochondrial proteins, specific extractions focused on the mitochondrial fraction can significantly improve signal-to-noise ratio.

• Blocking optimization: Test different blocking agents (BSA, non-fat dry milk, commercial blockers) to identify those that minimize background while preserving specific signal.

• Incubation conditions: Extended primary antibody incubation at 4°C (overnight or longer) can improve binding to low-abundance targets while using lower dilutions of antibody (e.g., 1:500 instead of 1:1000).

How can SPBC887.13c antibody be utilized to investigate mitochondrial fatty acid synthesis in relation to cellular stress responses?

SPBC887.13c antibody provides a valuable tool for investigating connections between mitochondrial fatty acid synthesis and cellular stress responses:

• Stress-induced expression changes: Researchers can quantify SPBC887.13c protein levels via Western blotting after exposing cells to various stressors (oxidative stress, nutrient deprivation, temperature shifts). This can reveal how mitochondrial fatty acid synthesis responds to cellular challenges, potentially uncovering regulatory mechanisms.

• Subcellular redistribution: Immunofluorescence using the SPBC887.13c antibody can track potential changes in localization patterns during stress responses. Co-staining with markers for different mitochondrial compartments can further characterize stress-induced reorganization.

• Protein-protein interaction dynamics: Employ co-immunoprecipitation with SPBC887.13c antibody followed by mass spectrometry to identify stress-specific interaction partners, potentially revealing stress-responsive regulatory mechanisms for mitochondrial fatty acid synthesis.

• Post-translational modifications: Use the antibody to immunoprecipitate SPBC887.13c under different stress conditions, followed by mass spectrometry analysis to identify stress-induced post-translational modifications that might regulate enzyme activity.

• Chronological lifespan studies: Given that mitochondrial function impacts chronological lifespan in yeast , the SPBC887.13c antibody could be used to investigate how expression patterns correlate with lifespan changes under various genetic or environmental conditions.

What methodological approaches can integrate SPBC887.13c antibody with multi-omics analyses to understand mitochondrial fatty acid synthesis networks?

Integrating antibody-based detection of SPBC887.13c with multi-omics approaches can provide comprehensive understanding of mitochondrial fatty acid synthesis networks:

• Antibody-based proteomics: Use SPBC887.13c antibody for immunoprecipitation followed by mass spectrometry (IP-MS) to identify protein interaction networks. Compare these networks under different conditions to identify context-dependent interactions.

• ChIP-seq integration: For transcription factors that might regulate SPBC887.13c expression, combine ChIP-seq data with protein expression quantification using the antibody to correlate binding events with actual protein abundance changes.

• Spatial proteomics: Employ the antibody in proximity labeling approaches (BioID or APEX2) by creating fusion proteins to map the proximal protein environment of SPBC887.13c in the mitochondrion under different conditions.

• Metabolomics correlation: Quantify SPBC887.13c protein levels across conditions or genetic backgrounds using the antibody, then correlate with metabolomic profiles focusing on fatty acids and lipoic acid derivatives to establish functional relationships.

• Single-cell analysis: Adapt the antibody for use in single-cell proteomic approaches or imaging mass cytometry to understand cell-to-cell variation in SPBC887.13c expression and correlate with other measured parameters.

• Computational integration: Develop computational workflows that integrate antibody-based quantification data with transcriptomics, metabolomics, and interaction data to build predictive models of mitochondrial fatty acid synthesis regulation.

How can SPBC887.13c antibody contribute to comparative studies of mitochondrial fatty acid synthesis across evolutionary diverse species?

The SPBC887.13c antibody can facilitate evolutionary studies of mitochondrial fatty acid synthesis through several approaches:

• Cross-species reactivity testing: Systematically test the antibody against homologous proteins in different species, from yeasts to higher eukaryotes. While the antibody was developed against the S. pombe protein, conserved epitopes might enable detection of homologs in related species, providing a tool for comparative studies.

• Functional conservation analysis: Use the antibody to compare subcellular localization, expression levels, and complex formation of SPBC887.13c homologs across species where cross-reactivity is confirmed. This can reveal evolutionary conservation or divergence in mitochondrial fatty acid synthesis organization.

• Complementation studies visualization: In experiments where SPBC887.13c homologs from different species are expressed in S. pombe, the antibody can be used to confirm expression and proper localization, complementing functional complementation data.

• Co-evolution of interaction networks: Apply co-immunoprecipitation with the antibody across species to identify conserved and divergent interaction partners, providing insights into the evolution of mitochondrial fatty acid synthesis regulation.

• Structural constraints analysis: If the antibody recognizes specific functional domains, its differential reactivity across species can provide insights into structural conservation of catalytically important regions versus more variable portions of the protein.

What emerging techniques might enhance SPBC887.13c antibody applications in future research?

Several emerging techniques hold promise for expanding SPBC887.13c antibody applications:

• Super-resolution microscopy: Techniques like STORM, PALM, or expansion microscopy could reveal unprecedented detail about SPBC887.13c distribution within mitochondrial subcompartments when used with fluorescently-labeled antibodies.

• Intrabody approaches: Developing single-chain antibody fragments derived from the SPBC887.13c antibody could enable live-cell imaging of the protein in its native environment or targeted perturbation of specific interactions.

• Antibody-guided CRISPR systems: Conjugating the antibody with CRISPR components could enable precise targeting of genomic modifications to cells with specific SPBC887.13c expression patterns or localizations.

• Spatially-resolved transcriptomics correlation: Combining immunofluorescence using the SPBC887.13c antibody with spatial transcriptomics could reveal localized translational regulation affecting mitochondrial fatty acid synthesis.

• Cryo-electron tomography with immunogold labeling: Using the antibody with gold nanoparticles could help localize SPBC887.13c within the native mitochondrial ultrastructure at molecular resolution.

• Microfluidic applications: Integrating the antibody into microfluidic immunocapture devices could enable single-cell analysis of SPBC887.13c expression correlated with functional parameters.

These emerging approaches represent the frontier of antibody-based research and could significantly expand our understanding of SPBC887.13c's role in mitochondrial fatty acid synthesis and cellular metabolism.